# Karyopharm Therapeutics Inc. (KPTI): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Karyopharm Therapeutics Inc. (KPTI) is 16/100, ranked against 24,000+ stocks in 35 markets (Quality 33, Value 35, Momentum 26, each scored against its sector).

- StockRank: 16/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 33, Value 35, Momentum 26: each a 0-100 percentile within Healthcare.
- Position: #22,341 overall, #2,066 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 0.4821 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 38K.

Source: https://moatmap.ai/stock/KPTI
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker